<H1>Chapter DOI: 10.1007/s00105-015-3698-6<br/>Cited-By Count: 0</H1><table border="1" width="30%"><tr><td>Total References</td><td>35</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>34</td></tr><tr><td>BibStructured Count</td><td width="10%">32</td></tr><tr><td>BibUnstructured Count</td><td width="10%">3</td></tr><tr><td>DOI already available in SpringerLink</td><td>25</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>3</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>2</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>2</td></tr><tr><td>Valid DOI Enriched</td><td>3</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Lee SH, Jeong SK, Ahn SK (2006) An update of the defensive barrier function of skin. Yonsei Med J 47(3):293&#8211;306</td><td><a href=http://dx.doi.org/10.3349/ymj.2006.47.3.293>10.3349/ymj.2006.47.3.293</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Ramos-e-Silva M, Jacques C (2012) Epidermal barrier function and systemic diseases. Clin Dermatol 30(3):277&#8211;279</td><td><a href=http://dx.doi.org/10.1016/j.clindermatol.2011.08.025>10.1016/j.clindermatol.2011.08.025</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 17(12):1063&#8211;1072</td><td><a href=http://dx.doi.org/10.1111/j.1600-0625.2008.00786.x>10.1111/j.1600-0625.2008.00786.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Streilein JW (1983) Skin-associated lymphoid tissues (SALT): origins and functions. J Invest Dermatol 80(Suppl):12s&#8211;16s</td><td><a href=http://dx.doi.org/10.1038/jid.1983.4>10.1038/jid.1983.4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Tay SS, Roediger B, Tong PL et al (2013) The skin-resident immune network. Curr Dermatol Rep 3:13&#8211;22</td><td><a href=http://dx.doi.org/10.1007/s13671-013-0063-9>10.1007/s13671-013-0063-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Ono S, Kabashima K (2015) Proposal of inducible skin-associated lymphoid tissue (iSALT). Exp Dermatol 24(8):630&#8211;631</td><td><a href=http://dx.doi.org/10.1111/exd.12716>10.1111/exd.12716</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Stalder JF, Tennstedt D, Deleuran M et al (2014) Fragility of epidermis and its consequence in dermatology. J Eur Acad Dermatol Venereol 28(Suppl 4):1&#8211;18</td><td><a href=http://dx.doi.org/10.1111/jdv.12509>10.1111/jdv.12509</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Zenz R, Eferl R, Kenner L et al (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437(7057):369&#8211;375</td><td><a href=http://dx.doi.org/10.1038/nature03963>10.1038/nature03963</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Lowes MA, Su&#225;rez-Fari&#241;as M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227&#8211;255</td><td><a href=http://dx.doi.org/10.1146/annurev-immunol-032713-120225>10.1146/annurev-immunol-032713-120225</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Grozdev I, Korman N, Tsankov N (2014) Psoriasis as a systemic disease. Clin Dermatol 32(3):343&#8211;350</td><td><a href=http://dx.doi.org/10.1016/j.clindermatol.2013.11.001>10.1016/j.clindermatol.2013.11.001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Torres T, Bettencourt N (2014) Psoriasis: the visible killer. Rev Port Cardiol 33(2):95&#8211;99</td><td><a href=http://dx.doi.org/10.1016/j.repce.2013.06.033>10.1016/j.repce.2013.06.033</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, VolumeID, IssueID, Author_FamilyName_1, FirstPage, ArticleTitle, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Palfreeman AC, McNamee KE, McCann FE (2013) New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast. Drug Des Devel Ther 7:201&#8211;210</td><td><a href=http://dx.doi.org/10.2147/DDDT.S32713>10.2147/DDDT.S32713</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Chiricozzi</span> <span style='background:#DDDDDD'>A</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Su&#225;rez-Fari&#241;as</span> <span style='background:#DDDDDD'>M</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Fuentes-Duculan</span> <span style='background:#DDDDDD'>J</span></span> et al</aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#FFD9B3'>Increased expression of IL-17 pathway genes in non-lesional skin of moderate-to-severe psoriasis vulgaris</span> . Br J Dermatol. doi:10.1111/bjd.14034. (Epub ahead of print)</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Stawczyk-Macieja M, Szczerkowska-Dobosz A, R&#281;ba&#322;a K et al (2015) Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris. Postepy Dermatol Alergol 32(2):123&#8211;126</td><td><a href=http://dx.doi.org/10.5114/pdia.2014.44003>10.5114/pdia.2014.44003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Harden</span> <span style='background:#DDDDDD'>JL</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Krueger</span> <span style='background:#DDDDDD'>JG</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Bowcock</span> <span style='background:#DDDDDD'>AM</span></span></aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#FFD9B3'>The immunogenetics of psoriasis: a comprehensive review</span> . J Autoimmun. doi:10.1016/j.jaut.2015.07.008. (Epub ahead of print)</td><td><a href=http://dx.doi.org/10.1016/j.jaut.2015.07.008>10.1016/j.jaut.2015.07.008</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, Author_FamilyName_2, BookTitle</td><td>CrossRef</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Li N, Yamasaki K, Saito R et al (2014) Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36&#947; induction in human epidermal keratinocytes. J Immunol 193(10):5140&#8211;5148</td><td><a href=http://dx.doi.org/10.4049/jimmunol.1302574>10.4049/jimmunol.1302574</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Seledtsov VI, Seledtsova GV (2012) A balance between tissue-destructive and tissue-protective immunities: a role of toll-like receptors in regulation of adaptive immunity. Immunobiology 217(4):430&#8211;435</td><td><a href=http://dx.doi.org/10.1016/j.imbio.2011.10.011>10.1016/j.imbio.2011.10.011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Martin G, Gu&#233;rard S, Fortin MM et al (2012) Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact. Lab Invest 92(7):1058&#8211;1070</td><td><a href=http://dx.doi.org/10.1038/labinvest.2012.69>10.1038/labinvest.2012.69</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Iwakura Y, Ishigame H (2006) The IL-23/IL-17 axis in inflammation. J Clin Invest 116(5):1218&#8211;1222</td><td><a href=http://dx.doi.org/10.1172/JCI28508>10.1172/JCI28508</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Yu N, Liu S, Yi X et al (2015) Serum amyloid A induces interleukin-1&#946; secretion from keratinocytes via the NACHT, LRR and PYD domains-containing protein 3 inflammasome. Clin Exp Immunol 179(2):344&#8211;353</td><td><a href=http://dx.doi.org/10.1111/cei.12458>10.1111/cei.12458</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Choi MR, Choi DK, Sohn KC et al (2015) Inhibitory effect of <Emphasis Type="Italic">Paeonia lactiflora Pallas</Emphasis> extract (PE) on poly (I:C)-induced immune response of epidermal keratinocytes. Int J Clin Exp Pathol 8(5):5236&#8211;5241</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Cooper KD, Hammerberg C, Baadsgaard O et al (1990) Interleukin-1 in human skin: dysregulation in psoriasis. J Invest Dermatol 95(5 Suppl):24S&#8211;26S</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12505698>10.1111/1523-1747.ep12505698</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Garg T, Rath G, Goyal AK (2014) Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31(4):331&#8211;364</td><td><a href=http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.2014010122>10.1615/CritRevTherDrugCarrierSyst.2014010122</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Fernandez A (2015) Dermatology update: the dawn of targeted treatment. Cleve Clin J Med 82(5):309&#8211;320</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Zerbinati N, Portale S, Palmieri B et al (2012) A preliminary study to assess the efficacy of a new UVA1 laser for treatment of psoriasis. Photomed Laser Surg 30(10):610&#8211;614</td><td><a href=http://dx.doi.org/10.1089/pho.2012.3281>10.1089/pho.2012.3281</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Nistic&#242; SP, Saraceno R, Chiricozzi A et al (2013) UVA-1 laser in the treatment of palmoplantar pustular psoriasis. Photomed Laser Surg 31(9):434&#8211;438</td><td><a href=http://dx.doi.org/10.1089/pho.2013.3545>10.1089/pho.2013.3545</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>D&#8217;Erme</span> <span style='background:#DDDDDD'>AM</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Mateeva</span> <span style='background:#DDDDDD'>V</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Lotti</span> <span style='background:#DDDDDD'>T</span></span></aug> (<span style='background:#66FF66'>2015</span>) <span style='background:#FFD9B3'>UVA-1 laser: new device in phototherapeutic armamentarium of the dermatologist</span> . Dermatol Ther. doi:10.1111/dth.12245. (Epub ahead of print)</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1111/dth.12245>10.1111/dth.12245</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle, Author_FamilyName_2, Year</td><td>CrossRef</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Gariboldi S, Palazzo M, Zanobbio L et al (2009) Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther 22(6):497&#8211;510</td><td><a href=http://dx.doi.org/10.1016/j.pupt.2009.05.002>10.1016/j.pupt.2009.05.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>D&#8217;Amico L, Ruffini E, Ferracini R et al (2012) Low Dose of IL-12 stimulates T cell response in cultures of PBMCs derived from non small cell lung cancer patients. J Cancer Ther 3:337&#8211;342</td><td><a href=http://dx.doi.org/10.4236/jct.2012.324044>10.4236/jct.2012.324044</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Cardani D, Dusio GF, Luchini P et al (2013) Oral administration of interleukin-10 and anti-IL-1 antibody ameliorates experimental intestinal inflammation. Gastroenterol Res 6(4):124&#8211;133</td><td><a href=http://dx.doi.org/10.4021/gr556w>10.4021/gr556w</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Radice E, Miranda V, Bellone G (2014) Low-doses of sequential-kinetic-activated interferon-gamma enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study. Intern Immunopharm 19(1):66&#8211;73</td><td><a href=http://dx.doi.org/10.1016/j.intimp.2013.12.011>10.1016/j.intimp.2013.12.011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Roberti ML, Ricottini L, Capponi A et al (2014) Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents 28(1):133&#8211;139</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Luchetti P (2014) Increasing of visual function in patients with retinal atrophy treated with drugs of Low Dose Medicine. Monocentric retrospective observational study. Minerva Oftalmologica 56(3&#8211;4):53&#8211;61</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Barygina V, Becatti M, Lotti T et al (2015) Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci 79(2):163&#8211;170</td><td><a href=http://dx.doi.org/10.1016/j.jdermsci.2015.05.003>10.1016/j.jdermsci.2015.05.003</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Lotti T, Hercogova J, Wollina U et al (2015) Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents 29(1 Suppl):53&#8211;58</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>